117 related articles for article (PubMed ID: 11769722)
1. [Expression of cell adhesion molecule (CD44V6) in thyroid tumors and its significance].
Li L; Lin L; Qiu J
Zhonghua Nei Ke Za Zhi; 2001 Oct; 40(10):677-80. PubMed ID: 11769722
[TBL] [Abstract][Full Text] [Related]
2. Immunostaining of galectin-3 and CD44v6 using fine-needle aspiration for distinguishing follicular carcinoma from adenoma.
Maruta J; Hashimoto H; Yamashita H; Yamashita H; Noguchi S
Diagn Cytopathol; 2004 Dec; 31(6):392-6. PubMed ID: 15540177
[TBL] [Abstract][Full Text] [Related]
3. [Significance of galectin-3 and CD44v6 expression in differential diagnosis of thyroid nodules].
Wang LH; Zhao YJ; Wang XY; Yuan P; Xu WQ; Xiao JC; Xu JP; Luo BR
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):547-50. PubMed ID: 16438854
[TBL] [Abstract][Full Text] [Related]
4. [Expression of CD44V6 and nm23-H1 in thyroid papillary adenocarcinoma and lymph node metastasis].
Wei Q; Fan S
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(1):5-7, 30. PubMed ID: 10681781
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM
Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649
[TBL] [Abstract][Full Text] [Related]
6. Role of p53, CD44V6 and CD57 in differentiating between benign and malignant follicular neoplasms of the thyroid.
Nasir A; Catalano E; Calafati S; Cantor A; Kaiser HE; Coppola D
In Vivo; 2004; 18(2):189-95. PubMed ID: 15113046
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of E-cadherin expression in thyroid neoplasms.
Naito A; Iwase H; Kuzushima T; Nakamura T; Kobayashi S
J Surg Oncol; 2001 Mar; 76(3):176-80. PubMed ID: 11276021
[TBL] [Abstract][Full Text] [Related]
8. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
9. Differential (Ha-, K- and N-) ras p21 expression in benign and malignant human thyroid tumors: an immunohistochemical study.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Nakamura S; Hashimoto T
Anticancer Res; 1995; 15(3):755-9. PubMed ID: 7645954
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of nuclear protein kinase CK2α as a poor prognosis indicator in lymph node cancerous metastases of human thyroid cancers.
Guo M; Liu C; Qi FJ; Zhang XM; Ren LL; Liu YM; Meng ZC; Zhu ZT; Xiao JY
Asian Pac J Cancer Prev; 2014; 15(17):7425-32. PubMed ID: 25227853
[TBL] [Abstract][Full Text] [Related]
11. Mixed medullary-follicular thyroid carcinoma. Report of a case and review of the literature.
Kostoglou-Athanassiou I; Athanassiou P; Vecchini G; Gogou L; Kaldrymides P
Horm Res; 2004; 61(6):300-4. PubMed ID: 15153799
[TBL] [Abstract][Full Text] [Related]
12. [The significance of p63 expression in thyroid neoplasm].
Qian M; Wang J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Oct; 22(19):888-90, 893. PubMed ID: 19160863
[TBL] [Abstract][Full Text] [Related]
13. A case of mixed medullary and follicular cell carcinoma of the thyroid.
Ueki I; Ando T; Haraguchi A; Horie I; Imaizumi M; Hayashi T; Uga T; Usa T; Kawakami A
Intern Med; 2011; 50(12):1313-6. PubMed ID: 21673468
[TBL] [Abstract][Full Text] [Related]
14. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
[TBL] [Abstract][Full Text] [Related]
15. Retinoblastoma expression in thyroid neoplasms.
Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
[TBL] [Abstract][Full Text] [Related]
16. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
[TBL] [Abstract][Full Text] [Related]
17. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
[TBL] [Abstract][Full Text] [Related]
18. CD44v6 as a prognostic factor in cervical carcinoma FIGO stage IB.
Bouda J; Boudova L; Hes O; Havir M; Tempfer C; Kohlberger P; Svoboda T; Rokyta Z; Speiser P
Anticancer Res; 2005; 25(1B):617-22. PubMed ID: 15816636
[TBL] [Abstract][Full Text] [Related]
19. [Expression of MUC1, CD44v6, nm23 in gastric carcinomas and regional lymph node tissues and their association with invasion, metastasis, and prognosis of the tumor].
Li Y; Zhang JH; Kuang G; Yang JQ; Zhao Q; Wang XL; Jiao ZK; Zhang ZD; Wang LL
Ai Zheng; 2003 Sep; 22(9):985-9. PubMed ID: 12969535
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of survivin expression in thyroid follicular adenoma and carcinoma.
Haghpanah V; Shooshtarizadeh P; Heshmat R; Larijani B; Tavangar SM
Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):422-5. PubMed ID: 17122639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
